Pages that link to "Q46070761"
Jump to navigation
Jump to search
The following pages link to Selling Stem Cells in the USA: Assessing the Direct-to-Consumer Industry (Q46070761):
Displaying 50 items.
- Responsible Translation of Stem Cell Research: An Assessment of Clinical Trial Registration and Publications. (Q33659105) (← links)
- Cell therapy must be regulated as medicine (Q37192040) (← links)
- Ethical and Regulatory Challenges with Autologous Adult Stem Cells: A Comparative Review of International Regulations. (Q38372717) (← links)
- Adipose-Derived Stem Cells in Aesthetic Surgery: A Mixed Methods Evaluation of the Current Clinical Trial, Intellectual Property, and Regulatory Landscape. (Q38737927) (← links)
- Advances in bone marrow stem cell therapy for retinal dysfunction (Q38804673) (← links)
- Adipose tissue-derived stromal vascular fraction in regenerative medicine: a brief review on biology and translation. (Q39376213) (← links)
- Marketing of unproven stem cell-based interventions: A call to action (Q39416083) (← links)
- ClinicalTrials.gov, stem cells and 'pay-to-participate' clinical studies. (Q39443366) (← links)
- Implicit hype? Representations of platelet rich plasma in the news media (Q41326201) (← links)
- The Stem Cell Hard Sell: Report from a Clinic's Patient Recruitment Seminar (Q41916323) (← links)
- Unproven Stem Cell-Based Interventions: Advancing Policy through Stakeholder Collaboration. (Q42332597) (← links)
- The 5th Annual One Mind Summit: Lessons Learned About "Science Informing Brain Health Policies and Practice". (Q42380225) (← links)
- Regenerative medicine in India: trends and challenges in innovation and regulation (Q45874072) (← links)
- California cracks down on stem cell cowboys (Q46868509) (← links)
- Mesenchymal Stem Cells: Time to Change the Name! (Q47094268) (← links)
- Can harmonized regulation overcome intra-European differences? Insights from a European Phase III stem cell trial (Q47190431) (← links)
- A Comparative Analysis of Attitudes on Communication Toward Stem Cell Research and Regenerative Medicine Between the Public and the Scientific Community (Q47553326) (← links)
- Mesenchymal stem cells injections for knee osteoarthritis: a systematic overview. (Q47571899) (← links)
- Leveraging social media in the stem cell sector: exploring Twitter's potential as a vehicle for public information campaigns (Q47622747) (← links)
- 'No one here's helping me, what do you do?': addressing patient need for support and advice about stem cell treatments (Q47622771) (← links)
- Wicked policy issues in regenerative medicine and the need to explore new avenues for public engagement (Q47624333) (← links)
- Special focus issue on regenerative medicine in society: interdisciplinary perspectives (part I) - Foreword (Q47660981) (← links)
- The social production of evidence: regenerative medicine and the 21st Century Cures Act. (Q47667562) (← links)
- Identity and ownership issues in the regulation of autologous cells (Q47852426) (← links)
- Cell-based therapeutic strategies for multiple sclerosis (Q47885870) (← links)
- Accelerating regenerative medicine: the Japanese experiment in ethics and regulation (Q49613181) (← links)
- The Council of Europe and the prohibition on human germline genome editing (Q49988530) (← links)
- Ethical and Safety Issues of Stem Cell-Based Therapy. (Q50050571) (← links)
- The FDA and the US direct-to-consumer marketplace for stem cell interventions: a temporal analysis (Q50070329) (← links)
- Open for business: a comparative study of websites selling autologous stem cells in Australia and Japan (Q50073634) (← links)
- Current and emerging global themes in the bioethics of regenerative medicine: the tangled web of stem cell translation (Q50098711) (← links)
- Fake news portrayals of stem cells and stem cell research (Q50112862) (← links)
- Somatic Mutations and Clonal Hematopoiesis: Unexpected Potential New Drivers of Age-Related Cardiovascular Disease. (Q50115925) (← links)
- Regulating the advertising and promotion of stem cell therapies (Q50122051) (← links)
- Exploiting science? A systematic analysis of complementary and alternative medicine clinic websites' marketing of stem cell therapies (Q51766621) (← links)
- Four Food and Drug Administration draft guidance documents and the REGROW Act: a litmus test for future changes in human cell- and tissue-based products regulatory policy in the United States? (Q52558237) (← links)
- Can civil lawsuits stem the tide of direct-to-consumer marketing of unproven stem cell interventions. (Q52686004) (← links)
- Regulation: Rewriting the regenerative rulebook. (Q54634860) (← links)
- The involvement of Canadian physicians in promoting and providing unproven and unapproved stem cell interventions. (Q55259610) (← links)
- Mesenchymal Stem Cells for the Treatment of Idiopathic Pulmonary Fibrosis. (Q55379594) (← links)
- The malignant niche: safe spaces for toxic stem cell marketing. (Q55656432) (← links)
- Continuing Challenges in Advancing Preclinical Science in Skeletal Cell-Based Therapies and Tissue Regeneration (Q56395022) (← links)
- Concise Review: A Comprehensive Analysis of Reported Adverse Events in Patients Receiving Unproven Stem Cell-Based Interventions (Q56965233) (← links)
- Stem cell in urology-are we at the cusp of a new era? (Q57173749) (← links)
- Optimizing Clinical Use of Biologics in Orthopaedic Surgery: Consensus Recommendations From the 2018 AAOS/NIH U-13 Conference (Q57294605) (← links)
- A randomized, controlled study to evaluate the efficacy of intra-articular, autologous adipose tissue injections for the treatment of mild-to-moderate knee osteoarthritis compared to hyaluronic acid: a study protocol (Q57790226) (← links)
- Co-opting of ClinicalTrials.gov by patient-funded studies (Q57833359) (← links)
- Weaponizing Hope: Sources of Hope, Unrealistic Optimism, and Denial (Q57989789) (← links)
- Overcoming barriers to facilitate the regulation of multi-centre regenerative medicine clinical trials (Q58590567) (← links)
- Tackling Ethical Challenges of Premature Delivery of Stem Cell-Based Therapies: ISSCR 2018 Annual Meeting Focus Session Report (Q58635037) (← links)